Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
37
pubmed:dateCreated
2009-10-6
pubmed:abstractText
Here we report that T-cell lymphomas characterized by the expression of anaplastic lymphoma kinase (ALK+ TCL) fail to express the TNFalpha and frequently display DNA methylation of the TNFalpha gene promoter. While only a subset of the ALK+ TCL-derived cell lines showed a high degree of the promoter methylation, all 6 showed low to nondetectable expression of the TNFalpha mRNA, and none expressed the TNFalpha protein. All 14 ALK+ TCL tissue samples examined displayed some degree of the TNFalpha promoter methylation, which was the most prominent in the distal portion of the the promoter. Treatment with a DNA methyltransferase inhibitor, 5'-aza-2'-deoxy-cytidine (5-ADC), reversed the promoter methylation and led to the expression of TNFalpha mRNA and protein. Furthermore, in vitro DNA methylation of the promoter impaired its transcriptional activity in the luciferase reporter assay. This impairment was seen even if only either distal or proximal portion were methylated, with methylation of the former exerting a more profound inhibitory effect. Notably, the ALK+ TCL cell lines uniformly expressed the type 1 TNFalpha receptor (TNF-R1) protein known to transduce the TNFalpha-induced pro-apoptotic signals. Moreover, exogenous TNFalpha inhibited growth of the ALK+ TCL cell lines in a dose-dependent manner and induced activation of the members of the cell apoptotic pathway: Caspase 8 and caspase 3. These findings provide additional rationale for the therapeutic inhibition of DNA methyltransferases in ALK+ TCL. They also suggest that treatment with TNFalpha may be highly effective in this type of lymphoma.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-11021818, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-11964157, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-12438221, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-12483718, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-12560241, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-12657462, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-12876673, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-14528273, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-14630568, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-15317731, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-15870198, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-16015507, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-16185764, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-16210084, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-16469875, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-16614236, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-17255842, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-17320506, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-17613771, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-17922009, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-18509084, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-18928444, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-19022824, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-19275511, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-19393833, http://linkedlifedata.com/resource/pubmed/commentcorrection/19717436-9437207
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1091-6490
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
106
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
15843-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Lack of TNFalpha expression protects anaplastic lymphoma kinase-positive T-cell lymphoma (ALK+ TCL) cells from apoptosis.
pubmed:affiliation
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. qian2@mail.med.upenn.edu
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural